1. Home
  2. KLTR vs MDWD Comparison

KLTR vs MDWD Comparison

Compare KLTR & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.73

Market Cap

238.4M

Sector

Technology

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.74

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
MDWD
Founded
2006
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.4M
238.5M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
KLTR
MDWD
Price
$1.73
$18.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$37.50
AVG Volume (30 Days)
348.9K
90.0K
Earning Date
11-10-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,921,000.00
$20,932,000.00
Revenue This Year
$3.10
$15.89
Revenue Next Year
$1.24
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
1.88
6.15
52 Week Low
$1.36
$14.14
52 Week High
$2.82
$22.51

Technical Indicators

Market Signals
Indicator
KLTR
MDWD
Relative Strength Index (RSI) 55.78 55.59
Support Level $1.64 $18.55
Resistance Level $1.72 $19.30
Average True Range (ATR) 0.09 0.57
MACD 0.01 0.03
Stochastic Oscillator 63.46 62.91

Price Performance

Historical Comparison
KLTR
MDWD

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: